Combining Tumor Segmentation Masks with PET/CT Images and Clinical Data in a Deep Learning Framework for Improved Prognostic Prediction in Head and Neck Squamous Cell Carcinoma.
CT
Deep learning
Head and neck cancer
Oropharyngeal cancer
Outcome prediction model
PET
Progression-free survival
Segmentation mask
Journal
Head and neck tumor segmentation and outcome prediction : second challenge, HECKTOR 2021, held in conjunction with MICCAI 2021, Strasbourg, France, September 27, 2021, Proceedings. Head and Neck Tumor Segmentation Challenge (2nd : 2021 ...
Titre abrégé: Head Neck Tumor Segm Chall (2021)
Pays: Switzerland
ID NLM: 9918367876306676
Informations de publication
Date de publication:
2022
2022
Historique:
entrez:
11
4
2022
pubmed:
12
4
2022
medline:
12
4
2022
Statut:
ppublish
Résumé
PET/CT images provide a rich data source for clinical prediction models in head and neck squamous cell carcinoma (HNSCC). Deep learning models often use images in an end-to-end fashion with clinical data or no additional input for predictions. However, in the context of HNSCC, the tumor region of interest may be an informative prior in the generation of improved prediction performance. In this study, we utilize a deep learning framework based on a DenseNet architecture to combine PET images, CT images, primary tumor segmentation masks, and clinical data as separate channels to predict progression-free survival (PFS) in days for HNSCC patients. Through internal validation (10-fold cross-validation) based on a large set of training data provided by the 2021 HECKTOR Challenge, we achieve a mean C-index of 0.855 ± 0.060 and 0.650 ± 0.074 when observed events are and are not included in the C-index calculation, respectively. Ensemble approaches applied to cross-validation folds yield C-index values up to 0.698 in the independent test set (external validation), leading to a 1
Identifiants
pubmed: 35399870
doi: 10.1007/978-3-030-98253-9_28
pmc: PMC8991448
mid: NIHMS1791918
doi:
Types de publication
Journal Article
Langues
eng
Pagination
300-307Subventions
Organisme : NCI NIH HHS
ID : P30 CA016672
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA214825
Pays : United States
Organisme : NIBIB NIH HHS
ID : R25 EB025787
Pays : United States
Organisme : NIDCR NIH HHS
ID : R56 DE025248
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA218148
Pays : United States
Organisme : NIDCR NIH HHS
ID : F31 DE031502
Pays : United States
Organisme : NCI NIH HHS
ID : P50 CA097007
Pays : United States
Organisme : NIDCR NIH HHS
ID : R01 DE028290
Pays : United States
Organisme : NCATS NIH HHS
ID : TL1 TR003169
Pays : United States
Références
IEEE Signal Process Mag. 2019 Jan;36(1):164-173
pubmed: 31543691
Front Genet. 2021 Feb 10;12:624820
pubmed: 33643386
PeerJ. 2019 Jan 25;7:e6257
pubmed: 30701130
Radiat Oncol. 2016 Jul 26;11(1):95
pubmed: 27460585
Imaging Med. 2012 Dec;4(6):633-647
pubmed: 23482696
Med Image Anal. 2022 Apr;77:102336
pubmed: 35016077
Radiology. 2020 Jul;296(1):216-224
pubmed: 32396042
Head Neck Tumor Segm Chall (2021). 2022;13209:287-299
pubmed: 35399868
J Imaging. 2020 Jun 20;6(6):
pubmed: 34460598
Sci Rep. 2019 Feb 26;9(1):2764
pubmed: 30809047